Clinical Trial Update: Ofatumumab in Japanese Patients With CD20 Positive Follicular Lymphoma or Chronic Lymphocytic Leukemia [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update for the anti-CD20 antibody ofatumumab in Japanese patients with CD20-positive follicular lymphoma or chronic lymphocytic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Follicular Lymphoma

Drugs mentioned

• Arzerra (ofatumumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Leukaemia, Lymphocytic, Chronic and Lymphoma, Follicular | Phase 1 | Status: COMPLETED